NUTX

DeTillio Joshua

Known title: Chief Operating OfficerCIK: 0001997130

DeTillio Joshua's purchase track record

How the stock did after each of DeTillio Joshua's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
3
of 3 since November 15, 2023
Stock higher 6 months later
67%
3 months: 67%
Median 6-month return
+272.6%
3 months: +58.7%
Beat the S&P 500
67%
median +263.3% vs. index
PurchaseStockAmount3 months6 months
8/19/2024NUTX$33K+58.7%+272.6%
6/12/2024NUTX$11K+328.5%+517.2%
11/15/2023NUTX$34K-50.2%-80.5%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

Nutex Health highlighted in recent healthcare stock roundups. Nutex Health appeared in a Seeking Alpha roundup of top healthcare stocks and in a Yahoo list of stocks to watch in October. The mentions place the company among peers that analysts consider noteworthy. This exposure comes while the stock trades near its recent support level.

this person other insiders at NUTX

Transaction History

NUTX▼ Sell$33K
NUTX▲ Buy$0
NUTX▲ Buy$10K
NUTX▲ Buy$23K
NUTX▲ Buy$11K
NUTX▲ Buy$34K

We use analytics to understand how market-wall is used. No personal data is sold.